A large-scale validation study of the Medication Adherence Rating Scale (MARS)

Schizophrenia Research

Volumn 100, Issue 1-3, 2008, Pages 53-59

  Fialko, Laura ^a   Garety, Philippa A ^a   Kuipers, Elizabeth ^a   Dunn, Graham ^b   Bebbington, Paul E ^c   Fowler, David ^d   Freeman, Daniel ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^d UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

Adherence; Compliance; Medication; Psychosis; Scale; Validity

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH BEHAVIOR; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION ADHERENCE RATING SCALE; MENTAL DISEASE; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOSIS; QUESTIONNAIRE; RATING SCALE; RELIABILITY; SELF REPORT; VALIDATION STUDY; VALIDITY;

ADULT; ANTIPSYCHOTIC AGENTS; ATTITUDE TO HEALTH; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; PATIENT COMPLIANCE; PERSONALITY INVENTORY; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; PSYCHOTIC DISORDERS; QUESTIONNAIRES; RECURRENCE; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SCHIZOPHRENIA, PARANOID; SCHIZOPHRENIC PSYCHOLOGY;

EID: 39949084492     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.10.029     Document Type: Article

References (26)

1. Amador X.F., Strauss D.H., Yale S.A., Flaum M.M., Endicott J., and Gorman J.M. Assessment of insight in psychosis. American Journal of Psychiatry 150 6 (1993) 873-879
2. Ayuso-Gutierrez J.L., and del Rio Vega J.M. Factors influencing relapse in the long-term course of schizophrenia. Schizophrenia Research 28 (1997) 199-206
3. Buckley P.F., Wirshing D.A., Bhushan P., Pierre J.M., Resnick S.A., and Wirshing W.C. Lack of insight in schizophrenia: impact on treatment adherence. CNS Drugs 21 (2007) 129-141
4. Chen E.Y.H., Hui C.L.M., Dunn E.L.W., Miao M.Y.K., Yeung W.S., Wong C.K., Chan W.F., and Tang W.N. A prospective 3-year longitudinal study of cognitive predictors of relapse in first-episode schizophrenic patients. Schizophrenia Research 77 (2005) 99-104
5. Cochran S.D., and Gitlin M.J. Attitudinal correlates of lithium compliance in bipolar affective disorders. Journal of Nervous and Mental Disease 176 (1988) 457-464
6. David A.S. Insight and psychosis. British Journal of Psychiatry 156 (1990) 798-808
7. Farmer K.C. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clinical Therapeutics 21 (1999) 1074-1090
8. Fenton W.S., Blyler C.R., and Heinssen R.K. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophrenia Bulletin 23 (1997) 637-651
9. Gray R., Wykes T., and Gournay K. From compliance to concordance: a review of the literature on interventions to enhance compliance with antipsychotic medication. Journal of Psychiatric and Mental Health Nursing 9 (2002) 277-284
10. Haywood T.W., Kravitz H.M., Grossman L.S., Cavanaugh J.L., Davis J.M., and Lewis D.A. Predicting the revolving-door phenomenon among patients with schizophrenic, schizoaffective, and affective-disorders. American Journal of Psychiatry 152 (1995) 856-861
11. Hall M., Meaden A., Smith J., and Jones C. The development and psychometric properties of an observer-rated measure of engagement with mental health services. Journal of Mental Health 10 4 (2001) 457-465
12. Helgason L. 20 years follow-up of 1st psychiatric presentation for schizophrenia - what could have been prevented. Acta Psychiatrica Scandinavica 81 (1990) 231-235
13. Hogan T.P., Awad A.G., and Eastwood R. A self-report scale predictive of drug compliance in schizophrenics - reliability and discriminative validity. Psychological Medicine 13 (1983) 177-183
14. Kampman O., and Lehtinen K. Compliance in psychoses. Acta Psychiatrica Scandinavica 100 (1999) 167-175
15. Kay S.R., Fiszbein A., and Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophrenia Bulletin 13 (1987) 261-276
16. Leucht S., and Heres S. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia. Journal of Clinical Psychiatry 67 (2006) 3-8
17. Mcevoy J.P., Johnson J., Perkins D., Lieberman J.A., Hamer R.M., Keefe R.S.E., et al. Insight in first-episode psychosis. Psychological Medicine 36 (2006) 1385-1393
18. Morisky D.E., Green L.W., and Levine D.M. Concurrent and predictive validity of a self-reported measure of medication adherence. Medical Care 24 (1986) 67-74
19. Nosé M., Barbui C., and Tansella M. How often do patients with psychosis fail to adhere to treatment programmes? A systematic review. Psychological Medicine 33 (2003) 1149-1160
20. Olfson M., Mechanic D., Hansell S., Boyer C.A., Walkup J., and Weiden P.J. Predicting medication noncompliance after hospital discharge among patients with schizophrenia. Psychiatric Services 51 (2000) 216-222
21. Perkins D.O. Adherence to antipsychotic medications. Journal of Clinical Psychiatry 60 (1999) 25-30
22. Perkins D.O. Predictors of noncompliance in patients with schizophrenia. Journal of Clinical Psychiatry 63 (2002) 1121-1128
23. Piatkowska O., and Farnhill D. Medication - compliance or alliance? A client-centred approach in increasing adherence. In: Kavanagh D.J. (Ed). Schizophrenia. An overview and practical handbook (1992), Chapman & Hall, London
24. Robinson D., Woerner M.G., Alvir J.M.J., Bilder R., Goldman R., Geisler S., Koreen A., Sheitman B., Chakos M., Mayerhoff D., and Lieberman J.A. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Archives of General Psychiatry 56 (1999) 241-247
25. Thompson K., Kulkarni J., and Sergejew A.A. Reliability and validity of a new Medication Adherence Rating Scale (MARS) for the psychoses. Schizophrenia Research 42 (2000) 241-247
26. Young J.L., Zonana H.V., and Shepler L. Medication noncompliance in schizophrenia: codification and update. Bulletin of the American Academy of Psychiatry and the Law 14 (1986) 105-122